CDSCO UID IMP/MD/2018/000223_ffb654f56d37665dc6d08ab16760bc52_4a5819c99aec727cdae06290bcf857e6

Architect LH Reagent

Name: Architect LH Reagent — CDSCO UID IMP/MD/2018/000223_ffb654f56d37665dc6d08ab16760bc52_4a5819c99aec727cdae06290bcf857e6
Creator: Abbott Healthcare Pvt. Ltd.
Keywords: Architect LH Reagent, IMP/MD/2018/000223_ffb654f56d37665dc6d08ab16760bc52_4a5819c99aec727cdae06290bcf857e6, ARCHTECT Total T4 Controls, Device Class Class B, Abbott Healthcare Pvt. Ltd., CDSCO registration

Abbott Healthcare Pvt. Ltd.Device Class Class BIndia CDSCOBrand: ARCHTECT Total T4 Controls

VerifiedCDSCO · official registry

Registration details

UID: IMP/MD/2018/000223_ffb654f56d37665dc6d08ab16760bc52_4a5819c99aec727cdae06290bcf857e6
Device class: Class B
Brand name: ARCHTECT Total T4 Controls
License holder: Abbott Healthcare Pvt. Ltd.
Approving authority: CDSCO
Product information: The ARCHITECT LH assay is a chemiluminescent microparticle immunoassay (ARCHTECT Total T4 Controls) for the quantitative determination of human luteinizing hormone (ARCHTECT Total T4 Controls) in human serum and plasma

About this record

Architect LH Reagent is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2018/000223_ffb654f56d37665dc6d08ab16760bc52_4a5819c99aec727cdae06290bcf857e6. This device is marketed under the brand name ARCHTECT Total T4 Controls. The license holder is Abbott Healthcare Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides the facts attached to this CDSCO registry row. Other records from the same license holder are available through the database search link without adding aggregation queries to this page. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.